Rain Oncology Inc.’s recently made public that its 10% Owner TANG KEVIN C acquired Company’s shares for reported $0.37 million on Jun 01. In the deal valued at $1.11 per share,333,325 shares were bought. As a result of this transaction, TANG KEVIN C now holds 3,740,341 shares worth roughly $ 3.85 million.
Then, TANG KEVIN C bought 166,180 shares, generating $179,574 in total proceeds. Upon buying the shares at $1.08, the 10% Owner now owns 3,407,016 shares.
Before that, TANG KEVIN C bought 588,768 shares. Rain Oncology Inc. shares valued at $608,655 were divested by the 10% Owner at a price of $1.03 per share. As a result of the transaction, TANG KEVIN C now holds 3,240,836 shares, worth roughly $3.34 million.
ROTH MKM downgraded its Rain Oncology Inc. [RAIN] rating to a Neutral from a a Buy in a research note published on Friday.
Price Performance Review of RAIN
On Friday, Rain Oncology Inc. [NASDAQ:RAIN] saw its stock fall -1.90% to $1.03. On the same session, the stock had its day’s lowest price of $0.9778, but rose to a high of $1.06. Over the last five days, the stock has gained 0.98%. Rain Oncology Inc. shares have fallen nearly -87.13% since the year began. Nevertheless, the stocks have fallen -82.63% over the past one year. While a 52-week high of $14.48 was reached on 01/10/23, a 52-week low of $0.94 was recorded on 05/30/23. SMA at 50 days reached $1.1947, while 200 days put it at $5.8297. A total of 0.29 million shares were traded, compared to the trading of 94300.0 shares in the previous session.
Levels Of Support And Resistance For RAIN Stock
The 24-hour chart illustrates a support level at 0.9852, which if violated will result in even more drops to 0.9404. On the upside, there is a resistance level at 1.0674. A further resistance level may holdings at 1.1048. The Relative Strength Index (RSI) on the 14-day chart is 34.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0043, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.63%. Stochastics %K at 43.85% indicates the stock is a holding.
How much short interest is there in Rain Oncology Inc.?
A steep rise in short interest was recorded in Rain Oncology Inc. stocks on Aug 14, 2023, dropping by -0.22 million shares to a total of 1.08 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 1.3 million shares. There was a decline of -20.37%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 8.19% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.55.
According to FactSet, Rain Oncology Inc.’s share price will average $1.58 in the next year, based on opinions of analysts polled by the firm. This is up nearly 66.67 percent from its previous closing price of $1.05. Analysts expect Rain Oncology Inc. stock to reach the higher price of $2.00, while the lowest price estimate is $1.00. However, 7 analysts have rated RAIN stock as a Hold in their predictions for 2023.